Propanc Biopharma Inc Sustainability Reports
A development-stage biotechnology company focused on developing new cancer treatments for patients suffering from solid tumors, such as pancreatic, ovarian, and colorectal cancers.
Sector: Manufacturing
Country: Australia
Exchange: OTC Markets
LEI: 549300Q3HY827FNV8Y56
FIGI: BBG002086411
2 reports from 2020 to 2024
